RYBELSUS14MG10TAB

Rybelsus is an oral medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. By mimicking the incretin hormone, it stimulates insulin secretion and lowers glucagon secretion in a glucose-dependent manner, while also slowing gastric emptying. This medication is designed for once-daily oral administration and represents a significant advancement in the management of type 2 diabetes, helping patients achieve better blood sugar regulation.